SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: S. maltophilia who wrote (5169)8/10/1998 4:15:00 PM
From: Peter V  Read Replies (1) | Respond to of 7041
 
<<all product rights under the agreement have reverted to the Company.>>

Thank goodness they go the rights back to a potential vaccine for which they never achieved any R&D milestones. Should be a winner.



To: S. maltophilia who wrote (5169)8/10/1998 8:42:00 PM
From: Linda Kaplan  Respond to of 7041
 
Well, Schering AG didn't think ZONA's stock was worth buying. :-)

Linda